Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CollPlant Biotechnologies (CLGN) Return on Equity (2020 - 2025)

CollPlant Biotechnologies filings provide 6 years of Return on Equity readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2025 for CollPlant Biotechnologies, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2021 to a low of 0.0% in Q1 2023.
  • Median Return on Equity over the past 5 years was 0.0% (2023), compared with a mean of 0.0%.
  • The widest YoY moves for Return on Equity: up 2bps in 2021, down 0bps in 2021.
  • CollPlant Biotechnologies' Return on Equity stood at 0.0% in 2021, then crashed by -262bps to 0.0% in 2022, then skyrocketed by 103bps to 0.0% in 2023, then skyrocketed by 564bps to 0.0% in 2024, then plummeted by -433bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.